Profitability
Weight: 20%
B
70
- 5yr Avg ROIC 31.7%
- Operating Margin Trend -6.65 pp/yr
IRWD
Ironwood Pharmaceuticals, Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
Capital Efficiency
Weight: 15%
F
18
- 5yr Avg ROE 0.0%
- 5yr Share-Count CAGR 2.0%
Growth Quality
Weight: 15%
F
10
- 5yr Revenue CAGR -8.0%
- 5yr EPS CAGR -53.5%
- Revenue-Growth Years (5) 2/5
Cash Generation
Weight: 15%
A-
84
- 5yr FCF Margin 48.7%
- 5yr FCF/NI Conversion 31.21x
Balance Sheet
Weight: 20%
D-
30
- Net Debt / EBITDA 3.65x
- Interest Coverage (EBIT/Int) 3.14x
- Altman Z-Score -2.02
Stability
Weight: 15%
D
33
- EPS Volatility (σ/μ) 1.30
- Piotroski F-Score 7
- Negative-Revenue Years (5) 3/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 1 new buy; 1 trimmed.
- Holders
- 2 +1
- Avg Δ position
- -59.2%
- New buys
- 1
- Full exits
- 0
- Greenblatt new
- Cooperman decreased -59%